Prognostic value of tumour blood flow, [18F]EF5 and [18F]FDG PET/CT imaging in patients with head and neck cancer treated with ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-06-05

AUTHORS

Gaber Komar, Kaisa Lehtiö, Marko Seppänen, Olli Eskola, Helena Levola, Paula Lindholm, Hannu Sipilä, Jan Seppälä, Reidar Grénman, Olof Solin, Heikki Minn

ABSTRACT

PurposeIn order to improve the treatment of squamous cell carcinoma of the head and neck, precise information on the treated tumour’s biology is required and the prognostic importance of different biological parameters needs to be determined. The aim of our study was to determine the predictive value of pretreatment PET/CT imaging using [18F]FDG, a new hypoxia tracer [18F]EF5 and the perfusion tracer [15O]H2O in patients with squamous cell cancer of the head and neck treated with radiochemotherapy.MethodsThe study group comprised 22 patients with confirmed squamous cell carcinoma of the head and neck who underwent a PET/CT scan using the above tracers before any treatment. Patients were later treated with a combination of radiochemotherapy and surgery. Parametric blood flow was calculated from dynamic [15O]H2O PET images using a one-tissue compartment model. [18F]FDG images were analysed by calculating standardized uptake values (SUV) and metabolically active tumour volumes (MATV). [18F]EF5 images were analysed by calculating tumour-to-muscle uptake ratios (T/M ratio). A T/M ratio of 1.5 was considered a significant threshold and used to determine tumour hypoxic subvolumes (HS) and hypoxic fraction area. The findings were finally correlated with the pretreatment clinical findings (overall stage and TNM stage) as well as the outcome following radiochemotherapy in terms of local control and overall patient survival.ResultsTumour stage and T-classification did not show any significant differences in comparison to the patients’ metabolic and functional characteristics measured on PET. Using the Cox proportional hazards model, a shorter overall survival was associated with MATV (p = 0.008, HR = 1.108), maximum [18F]EF5 T/M ratio (p = 0.0145, HR = 4.084) and tumour HS (p = 0.0047, HR = 1.112). None of the PET parameters showed a significant effect on patient survival in the log-rank test, although [18F]EF5 maximum T/M ratio was the closest (p = 0.109). By contrast, tumour blood flow was not correlated with any of the clinical endpoints. There were no statistically significant correlations among [18F]FDG SUVmax, [18F]EF5 T/M ratio and blood flow.ConclusionOur study in a limited number of patients confirmed the importance of MATV in the prognosis of locally advanced squamous cell carcinoma of the head and neck. It is of interest that high uptake of the hypoxia tracer [18F]EF5 showed a stronger correlation with a poor clinical outcome than [18F]FDG uptake. This confirms the importance of hypoxia in treatment outcome and suggests that [18F]EF5 may act as a surrogate marker of radioresistance. More... »

PAGES

2042-2050

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-014-2818-3

DOI

http://dx.doi.org/10.1007/s00259-014-2818-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1002687640

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24898846


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemoradiotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Etanidazole", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorodeoxyglucose F18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Head and Neck Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydrocarbons, Fluorinated", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multimodal Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Positron-Emission Tomography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tomography, X-Ray Computed", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Turku PET Centre, Kiinamyllynkatu 4-8, 20521, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, Kiinamyllynkatu 4-8, 20521, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Komar", 
        "givenName": "Gaber", 
        "id": "sg:person.01045317743.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045317743.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.1374.1", 
          "name": [
            "Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lehti\u00f6", 
        "givenName": "Kaisa", 
        "id": "sg:person.01047176562.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047176562.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Turku University Hospital and University of Turku, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.1374.1", 
          "name": [
            "Turku PET Centre, Kiinamyllynkatu 4-8, 20521, Turku, Finland", 
            "Department of Nuclear Medicine, Turku University Hospital and University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sepp\u00e4nen", 
        "givenName": "Marko", 
        "id": "sg:person.01231750412.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231750412.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre, Kiinamyllynkatu 4-8, 20521, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, Kiinamyllynkatu 4-8, 20521, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eskola", 
        "givenName": "Olli", 
        "id": "sg:person.01310420600.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310420600.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.1374.1", 
          "name": [
            "Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Levola", 
        "givenName": "Helena", 
        "id": "sg:person.01313665410.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313665410.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.1374.1", 
          "name": [
            "Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lindholm", 
        "givenName": "Paula", 
        "id": "sg:person.01036132326.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036132326.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre, Kiinamyllynkatu 4-8, 20521, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, Kiinamyllynkatu 4-8, 20521, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sipil\u00e4", 
        "givenName": "Hannu", 
        "id": "sg:person.01206306567.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206306567.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.1374.1", 
          "name": [
            "Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sepp\u00e4l\u00e4", 
        "givenName": "Jan", 
        "id": "sg:person.01117730525.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117730525.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Otorhinolaryngology, Head and Neck Surgery, Turku University Hospital and University of Turku, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.1374.1", 
          "name": [
            "Department of Otorhinolaryngology, Head and Neck Surgery, Turku University Hospital and University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gr\u00e9nman", 
        "givenName": "Reidar", 
        "id": "sg:person.0734615422.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734615422.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre, Kiinamyllynkatu 4-8, 20521, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, Kiinamyllynkatu 4-8, 20521, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Solin", 
        "givenName": "Olof", 
        "id": "sg:person.0656631675.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656631675.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.1374.1", 
          "name": [
            "Turku PET Centre, Kiinamyllynkatu 4-8, 20521, Turku, Finland", 
            "Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Minn", 
        "givenName": "Heikki", 
        "id": "sg:person.0700413711.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700413711.55"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00259-011-1789-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043774202", 
          "https://doi.org/10.1007/s00259-011-1789-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12149-012-0604-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011120417", 
          "https://doi.org/10.1007/s12149-012-0604-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00405-010-1348-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000401648", 
          "https://doi.org/10.1007/s00405-010-1348-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-011-1755-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051740136", 
          "https://doi.org/10.1007/s00259-011-1755-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-007-0493-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010148911", 
          "https://doi.org/10.1007/s00259-007-0493-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12149-013-0686-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023625651", 
          "https://doi.org/10.1007/s12149-013-0686-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11307-011-0484-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046913665", 
          "https://doi.org/10.1007/s11307-011-0484-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-008-0888-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028197678", 
          "https://doi.org/10.1007/s00259-008-0888-9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-06-05", 
    "datePublishedReg": "2014-06-05", 
    "description": "PurposeIn order to improve the treatment of squamous cell carcinoma of the head and neck, precise information on the treated tumour\u2019s biology is required and the prognostic importance of different biological parameters needs to be determined. The aim of our study was to determine the predictive value of pretreatment PET/CT imaging using [18F]FDG, a new hypoxia tracer [18F]EF5 and the perfusion tracer [15O]H2O in patients with squamous cell cancer of the head and neck treated with radiochemotherapy.MethodsThe study group comprised 22 patients with confirmed squamous cell carcinoma of the head and neck who underwent a PET/CT scan using the above tracers before any treatment. Patients were later treated with a combination of radiochemotherapy and surgery. Parametric blood flow was calculated from dynamic [15O]H2O PET images using a one-tissue compartment model. [18F]FDG images were analysed by calculating standardized uptake values (SUV) and metabolically active tumour volumes (MATV). [18F]EF5 images were analysed by calculating tumour-to-muscle uptake ratios (T/M ratio). A T/M ratio of 1.5 was considered a significant threshold and used to determine tumour hypoxic subvolumes (HS) and hypoxic fraction area. The findings were finally correlated with the pretreatment clinical findings (overall stage and TNM stage) as well as the outcome following radiochemotherapy in terms of local control and overall patient survival.ResultsTumour stage and T-classification did not show any significant differences in comparison to the patients\u2019 metabolic and functional characteristics measured on PET. Using the Cox proportional hazards model, a shorter overall survival was associated with MATV (p\u2009=\u20090.008, HR\u2009=\u20091.108), maximum [18F]EF5 T/M ratio (p\u2009=\u20090.0145, HR\u2009=\u20094.084) and tumour HS (p\u2009=\u20090.0047, HR\u2009=\u20091.112). None of the PET parameters showed a significant effect on patient survival in the log-rank test, although [18F]EF5 maximum T/M ratio was the closest (p\u2009=\u20090.109). By contrast, tumour blood flow was not correlated with any of the clinical endpoints. There were no statistically significant correlations among [18F]FDG SUVmax, [18F]EF5 T/M ratio and blood flow.ConclusionOur study in a limited number of patients confirmed the importance of MATV in the prognosis of locally advanced squamous cell carcinoma of the head and neck. It is of interest that high uptake of the hypoxia tracer [18F]EF5 showed a stronger correlation with a poor clinical outcome than [18F]FDG uptake. This confirms the importance of hypoxia in treatment outcome and suggests that [18F]EF5 may act as a surrogate marker of radioresistance.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00259-014-2818-3", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "41"
      }
    ], 
    "keywords": [
      "squamous cell carcinoma", 
      "standardized uptake value", 
      "cell carcinoma", 
      "blood flow", 
      "patient survival", 
      "pretreatment PET/CT imaging", 
      "advanced squamous cell carcinoma", 
      "Cox proportional hazards model", 
      "hypoxia tracer", 
      "PET/CT scans", 
      "combination of radiochemotherapy", 
      "pretreatment clinical findings", 
      "squamous cell cancer", 
      "overall patient survival", 
      "shorter overall survival", 
      "poor clinical outcome", 
      "log-rank test", 
      "MethodsThe study group", 
      "PET/CT imaging", 
      "muscle uptake ratios", 
      "tumor blood flow", 
      "proportional hazards model", 
      "active tumor volume", 
      "PET/CT", 
      "importance of hypoxia", 
      "overall survival", 
      "cell cancer", 
      "clinical outcomes", 
      "prognostic importance", 
      "clinical findings", 
      "prognostic value", 
      "neck cancer", 
      "clinical endpoints", 
      "surrogate marker", 
      "tumor hypoxic", 
      "PET parameters", 
      "treatment outcomes", 
      "study group", 
      "tumor volume", 
      "CT scan", 
      "radiochemotherapy", 
      "one-tissue compartment model", 
      "hazards model", 
      "patients", 
      "predictive value", 
      "uptake value", 
      "local control", 
      "tumor biology", 
      "ConclusionOur study", 
      "carcinoma", 
      "CT imaging", 
      "neck", 
      "perfusion tracer", 
      "uptake ratio", 
      "high uptake", 
      "significant differences", 
      "significant correlation", 
      "survival", 
      "outcomes", 
      "cancer", 
      "PurposeIn order", 
      "M ratio", 
      "treatment", 
      "PET images", 
      "fraction area", 
      "significant threshold", 
      "head", 
      "compartment model", 
      "functional characteristics", 
      "MATV", 
      "different biological parameters", 
      "surgery", 
      "SUVmax", 
      "prognosis", 
      "tumors", 
      "findings", 
      "strong correlation", 
      "uptake", 
      "hypoxia", 
      "significant effect", 
      "endpoint", 
      "hypoxic", 
      "CT", 
      "radioresistance", 
      "scans", 
      "biological parameters", 
      "study", 
      "markers", 
      "limited number", 
      "tracer", 
      "correlation", 
      "imaging", 
      "group", 
      "PET", 
      "aim", 
      "ratio", 
      "differences", 
      "control", 
      "importance", 
      "biology", 
      "above tracers", 
      "HS", 
      "contrast", 
      "test", 
      "effect", 
      "volume", 
      "precise information", 
      "values", 
      "threshold", 
      "stage", 
      "combination", 
      "number", 
      "classification", 
      "comparison", 
      "area", 
      "flow", 
      "model", 
      "characteristics", 
      "images", 
      "information", 
      "parameters", 
      "interest", 
      "terms", 
      "order", 
      "new hypoxia tracer", 
      "Parametric blood flow", 
      "hypoxic fraction area", 
      "ResultsTumour stage", 
      "maximum T/M ratio", 
      "T/M ratio", 
      "importance of MATV"
    ], 
    "name": "Prognostic value of tumour blood flow, [18F]EF5 and [18F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy", 
    "pagination": "2042-2050", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1002687640"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-014-2818-3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24898846"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-014-2818-3", 
      "https://app.dimensions.ai/details/publication/pub.1002687640"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_626.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00259-014-2818-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-014-2818-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-014-2818-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-014-2818-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-014-2818-3'


 

This table displays all metadata directly associated to this object as RDF triples.

375 TRIPLES      22 PREDICATES      183 URIs      166 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-014-2818-3 schema:about N003235423de7485aabc1c0079d1736e7
2 N1765643a877e46ac823a7fe066e3dcbb
3 N1d1a3392ff1643c49ae4833e669b5ff3
4 N231f441785fa4cc0a6b0e64622b182d2
5 N2c25e319c2bc4ae2b7b21cb1616421c7
6 N37f7c5b678234f99966f3275caa5ddfa
7 N3eeb3ade0d084e65bbc871d8ce7475f7
8 N47b79805d5dd49ac84bbf80a282f4571
9 N5b76517e4a89405697165f3523766354
10 N6e2090353d2a49adb1c52d1dfba96088
11 N851ed4e9beca4093a850d719bd9ec2c4
12 N8fb7ae639de54433abeafa32b7f3a8cb
13 Na1845a14cb664b4d8419c7bd758e3aa3
14 Nb0359af189834533aab3ba6437825916
15 Nb6e488ec11a042ce9a8a6d7915676082
16 Nb9aba0f49b014955ae51a6e35c99291b
17 Nc8d6358a0e8043f8b4b04262c8ba4c54
18 anzsrc-for:11
19 anzsrc-for:1103
20 anzsrc-for:1112
21 schema:author N4abc0c6373464d55b506e4308810a360
22 schema:citation sg:pub.10.1007/s00259-007-0493-3
23 sg:pub.10.1007/s00259-008-0888-9
24 sg:pub.10.1007/s00259-011-1755-7
25 sg:pub.10.1007/s00259-011-1789-x
26 sg:pub.10.1007/s00405-010-1348-2
27 sg:pub.10.1007/s11307-011-0484-4
28 sg:pub.10.1007/s12149-012-0604-5
29 sg:pub.10.1007/s12149-013-0686-8
30 schema:datePublished 2014-06-05
31 schema:datePublishedReg 2014-06-05
32 schema:description PurposeIn order to improve the treatment of squamous cell carcinoma of the head and neck, precise information on the treated tumour’s biology is required and the prognostic importance of different biological parameters needs to be determined. The aim of our study was to determine the predictive value of pretreatment PET/CT imaging using [18F]FDG, a new hypoxia tracer [18F]EF5 and the perfusion tracer [15O]H2O in patients with squamous cell cancer of the head and neck treated with radiochemotherapy.MethodsThe study group comprised 22 patients with confirmed squamous cell carcinoma of the head and neck who underwent a PET/CT scan using the above tracers before any treatment. Patients were later treated with a combination of radiochemotherapy and surgery. Parametric blood flow was calculated from dynamic [15O]H2O PET images using a one-tissue compartment model. [18F]FDG images were analysed by calculating standardized uptake values (SUV) and metabolically active tumour volumes (MATV). [18F]EF5 images were analysed by calculating tumour-to-muscle uptake ratios (T/M ratio). A T/M ratio of 1.5 was considered a significant threshold and used to determine tumour hypoxic subvolumes (HS) and hypoxic fraction area. The findings were finally correlated with the pretreatment clinical findings (overall stage and TNM stage) as well as the outcome following radiochemotherapy in terms of local control and overall patient survival.ResultsTumour stage and T-classification did not show any significant differences in comparison to the patients’ metabolic and functional characteristics measured on PET. Using the Cox proportional hazards model, a shorter overall survival was associated with MATV (p = 0.008, HR = 1.108), maximum [18F]EF5 T/M ratio (p = 0.0145, HR = 4.084) and tumour HS (p = 0.0047, HR = 1.112). None of the PET parameters showed a significant effect on patient survival in the log-rank test, although [18F]EF5 maximum T/M ratio was the closest (p = 0.109). By contrast, tumour blood flow was not correlated with any of the clinical endpoints. There were no statistically significant correlations among [18F]FDG SUVmax, [18F]EF5 T/M ratio and blood flow.ConclusionOur study in a limited number of patients confirmed the importance of MATV in the prognosis of locally advanced squamous cell carcinoma of the head and neck. It is of interest that high uptake of the hypoxia tracer [18F]EF5 showed a stronger correlation with a poor clinical outcome than [18F]FDG uptake. This confirms the importance of hypoxia in treatment outcome and suggests that [18F]EF5 may act as a surrogate marker of radioresistance.
33 schema:genre article
34 schema:inLanguage en
35 schema:isAccessibleForFree false
36 schema:isPartOf N9392cc14fe8946e78feb2379672c8f85
37 Naa1de744591142e8bae3df72b0f3c2a8
38 sg:journal.1297401
39 schema:keywords CT
40 CT imaging
41 CT scan
42 ConclusionOur study
43 Cox proportional hazards model
44 HS
45 M ratio
46 MATV
47 MethodsThe study group
48 PET
49 PET images
50 PET parameters
51 PET/CT
52 PET/CT imaging
53 PET/CT scans
54 Parametric blood flow
55 PurposeIn order
56 ResultsTumour stage
57 SUVmax
58 T/M ratio
59 above tracers
60 active tumor volume
61 advanced squamous cell carcinoma
62 aim
63 area
64 biological parameters
65 biology
66 blood flow
67 cancer
68 carcinoma
69 cell cancer
70 cell carcinoma
71 characteristics
72 classification
73 clinical endpoints
74 clinical findings
75 clinical outcomes
76 combination
77 combination of radiochemotherapy
78 comparison
79 compartment model
80 contrast
81 control
82 correlation
83 differences
84 different biological parameters
85 effect
86 endpoint
87 findings
88 flow
89 fraction area
90 functional characteristics
91 group
92 hazards model
93 head
94 high uptake
95 hypoxia
96 hypoxia tracer
97 hypoxic
98 hypoxic fraction area
99 images
100 imaging
101 importance
102 importance of MATV
103 importance of hypoxia
104 information
105 interest
106 limited number
107 local control
108 log-rank test
109 markers
110 maximum T/M ratio
111 model
112 muscle uptake ratios
113 neck
114 neck cancer
115 new hypoxia tracer
116 number
117 one-tissue compartment model
118 order
119 outcomes
120 overall patient survival
121 overall survival
122 parameters
123 patient survival
124 patients
125 perfusion tracer
126 poor clinical outcome
127 precise information
128 predictive value
129 pretreatment PET/CT imaging
130 pretreatment clinical findings
131 prognosis
132 prognostic importance
133 prognostic value
134 proportional hazards model
135 radiochemotherapy
136 radioresistance
137 ratio
138 scans
139 shorter overall survival
140 significant correlation
141 significant differences
142 significant effect
143 significant threshold
144 squamous cell cancer
145 squamous cell carcinoma
146 stage
147 standardized uptake value
148 strong correlation
149 study
150 study group
151 surgery
152 surrogate marker
153 survival
154 terms
155 test
156 threshold
157 tracer
158 treatment
159 treatment outcomes
160 tumor biology
161 tumor blood flow
162 tumor hypoxic
163 tumor volume
164 tumors
165 uptake
166 uptake ratio
167 uptake value
168 values
169 volume
170 schema:name Prognostic value of tumour blood flow, [18F]EF5 and [18F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy
171 schema:pagination 2042-2050
172 schema:productId N1364ad37733f4318a58f3c57093185bd
173 N83b3f2130ec44ae3ae10890c21f402ad
174 Nd1aad2d1fd1b42fa88a485c77d9cc76b
175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002687640
176 https://doi.org/10.1007/s00259-014-2818-3
177 schema:sdDatePublished 2021-12-01T19:30
178 schema:sdLicense https://scigraph.springernature.com/explorer/license/
179 schema:sdPublisher N67e7b67213184ae4a39095d095fa30d9
180 schema:url https://doi.org/10.1007/s00259-014-2818-3
181 sgo:license sg:explorer/license/
182 sgo:sdDataset articles
183 rdf:type schema:ScholarlyArticle
184 N003235423de7485aabc1c0079d1736e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Adult
186 rdf:type schema:DefinedTerm
187 N1364ad37733f4318a58f3c57093185bd schema:name pubmed_id
188 schema:value 24898846
189 rdf:type schema:PropertyValue
190 N1765643a877e46ac823a7fe066e3dcbb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Aged
192 rdf:type schema:DefinedTerm
193 N1d1a3392ff1643c49ae4833e669b5ff3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Fluorodeoxyglucose F18
195 rdf:type schema:DefinedTerm
196 N231f441785fa4cc0a6b0e64622b182d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Female
198 rdf:type schema:DefinedTerm
199 N2c25e319c2bc4ae2b7b21cb1616421c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Young Adult
201 rdf:type schema:DefinedTerm
202 N2ed9d5f23aef44989410393430bd1208 rdf:first sg:person.01047176562.24
203 rdf:rest N8bddcaceb676499588756c654d89c9a5
204 N367ef9ba17b34bf78d29f9e950e2bc63 rdf:first sg:person.01310420600.55
205 rdf:rest Neb86ca798d70452b9e6a979a1f7eeaa6
206 N37f7c5b678234f99966f3275caa5ddfa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
207 schema:name Chemoradiotherapy
208 rdf:type schema:DefinedTerm
209 N3eeb3ade0d084e65bbc871d8ce7475f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
210 schema:name Humans
211 rdf:type schema:DefinedTerm
212 N410549d2dab24107befd601fa2dea3e5 rdf:first sg:person.01117730525.16
213 rdf:rest N9a0733c96fc042b18da590114edba3d4
214 N47b79805d5dd49ac84bbf80a282f4571 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
215 schema:name Hydrocarbons, Fluorinated
216 rdf:type schema:DefinedTerm
217 N4abc0c6373464d55b506e4308810a360 rdf:first sg:person.01045317743.33
218 rdf:rest N2ed9d5f23aef44989410393430bd1208
219 N4e49b1e51075410782c361677d9ae78b rdf:first sg:person.0700413711.55
220 rdf:rest rdf:nil
221 N5b76517e4a89405697165f3523766354 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
222 schema:name Head and Neck Neoplasms
223 rdf:type schema:DefinedTerm
224 N67e7b67213184ae4a39095d095fa30d9 schema:name Springer Nature - SN SciGraph project
225 rdf:type schema:Organization
226 N689164feae884731a7d729f5a03c0964 rdf:first sg:person.01206306567.04
227 rdf:rest N410549d2dab24107befd601fa2dea3e5
228 N6e2090353d2a49adb1c52d1dfba96088 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
229 schema:name Survival Analysis
230 rdf:type schema:DefinedTerm
231 N83b3f2130ec44ae3ae10890c21f402ad schema:name dimensions_id
232 schema:value pub.1002687640
233 rdf:type schema:PropertyValue
234 N851ed4e9beca4093a850d719bd9ec2c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
235 schema:name Etanidazole
236 rdf:type schema:DefinedTerm
237 N8bddcaceb676499588756c654d89c9a5 rdf:first sg:person.01231750412.31
238 rdf:rest N367ef9ba17b34bf78d29f9e950e2bc63
239 N8f607c6289f94400842f6ba5f33c8a52 rdf:first sg:person.0656631675.01
240 rdf:rest N4e49b1e51075410782c361677d9ae78b
241 N8fb7ae639de54433abeafa32b7f3a8cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
242 schema:name Middle Aged
243 rdf:type schema:DefinedTerm
244 N9392cc14fe8946e78feb2379672c8f85 schema:volumeNumber 41
245 rdf:type schema:PublicationVolume
246 N9a0733c96fc042b18da590114edba3d4 rdf:first sg:person.0734615422.13
247 rdf:rest N8f607c6289f94400842f6ba5f33c8a52
248 Na1845a14cb664b4d8419c7bd758e3aa3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
249 schema:name Prognosis
250 rdf:type schema:DefinedTerm
251 Na5ef1f02a3de4eb598cdfa27e2f68529 rdf:first sg:person.01036132326.09
252 rdf:rest N689164feae884731a7d729f5a03c0964
253 Naa1de744591142e8bae3df72b0f3c2a8 schema:issueNumber 11
254 rdf:type schema:PublicationIssue
255 Nb0359af189834533aab3ba6437825916 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
256 schema:name Tomography, X-Ray Computed
257 rdf:type schema:DefinedTerm
258 Nb6e488ec11a042ce9a8a6d7915676082 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
259 schema:name Multimodal Imaging
260 rdf:type schema:DefinedTerm
261 Nb9aba0f49b014955ae51a6e35c99291b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
262 schema:name Male
263 rdf:type schema:DefinedTerm
264 Nc8d6358a0e8043f8b4b04262c8ba4c54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
265 schema:name Positron-Emission Tomography
266 rdf:type schema:DefinedTerm
267 Nd1aad2d1fd1b42fa88a485c77d9cc76b schema:name doi
268 schema:value 10.1007/s00259-014-2818-3
269 rdf:type schema:PropertyValue
270 Neb86ca798d70452b9e6a979a1f7eeaa6 rdf:first sg:person.01313665410.06
271 rdf:rest Na5ef1f02a3de4eb598cdfa27e2f68529
272 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
273 schema:name Medical and Health Sciences
274 rdf:type schema:DefinedTerm
275 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
276 schema:name Clinical Sciences
277 rdf:type schema:DefinedTerm
278 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
279 schema:name Oncology and Carcinogenesis
280 rdf:type schema:DefinedTerm
281 sg:journal.1297401 schema:issn 1619-7070
282 1619-7089
283 schema:name European Journal of Nuclear Medicine and Molecular Imaging
284 schema:publisher Springer Nature
285 rdf:type schema:Periodical
286 sg:person.01036132326.09 schema:affiliation grid-institutes:grid.1374.1
287 schema:familyName Lindholm
288 schema:givenName Paula
289 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036132326.09
290 rdf:type schema:Person
291 sg:person.01045317743.33 schema:affiliation grid-institutes:grid.470895.7
292 schema:familyName Komar
293 schema:givenName Gaber
294 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045317743.33
295 rdf:type schema:Person
296 sg:person.01047176562.24 schema:affiliation grid-institutes:grid.1374.1
297 schema:familyName Lehtiö
298 schema:givenName Kaisa
299 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047176562.24
300 rdf:type schema:Person
301 sg:person.01117730525.16 schema:affiliation grid-institutes:grid.1374.1
302 schema:familyName Seppälä
303 schema:givenName Jan
304 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117730525.16
305 rdf:type schema:Person
306 sg:person.01206306567.04 schema:affiliation grid-institutes:grid.470895.7
307 schema:familyName Sipilä
308 schema:givenName Hannu
309 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206306567.04
310 rdf:type schema:Person
311 sg:person.01231750412.31 schema:affiliation grid-institutes:grid.1374.1
312 schema:familyName Seppänen
313 schema:givenName Marko
314 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231750412.31
315 rdf:type schema:Person
316 sg:person.01310420600.55 schema:affiliation grid-institutes:grid.470895.7
317 schema:familyName Eskola
318 schema:givenName Olli
319 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310420600.55
320 rdf:type schema:Person
321 sg:person.01313665410.06 schema:affiliation grid-institutes:grid.1374.1
322 schema:familyName Levola
323 schema:givenName Helena
324 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313665410.06
325 rdf:type schema:Person
326 sg:person.0656631675.01 schema:affiliation grid-institutes:grid.470895.7
327 schema:familyName Solin
328 schema:givenName Olof
329 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656631675.01
330 rdf:type schema:Person
331 sg:person.0700413711.55 schema:affiliation grid-institutes:grid.1374.1
332 schema:familyName Minn
333 schema:givenName Heikki
334 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700413711.55
335 rdf:type schema:Person
336 sg:person.0734615422.13 schema:affiliation grid-institutes:grid.1374.1
337 schema:familyName Grénman
338 schema:givenName Reidar
339 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734615422.13
340 rdf:type schema:Person
341 sg:pub.10.1007/s00259-007-0493-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010148911
342 https://doi.org/10.1007/s00259-007-0493-3
343 rdf:type schema:CreativeWork
344 sg:pub.10.1007/s00259-008-0888-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028197678
345 https://doi.org/10.1007/s00259-008-0888-9
346 rdf:type schema:CreativeWork
347 sg:pub.10.1007/s00259-011-1755-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051740136
348 https://doi.org/10.1007/s00259-011-1755-7
349 rdf:type schema:CreativeWork
350 sg:pub.10.1007/s00259-011-1789-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1043774202
351 https://doi.org/10.1007/s00259-011-1789-x
352 rdf:type schema:CreativeWork
353 sg:pub.10.1007/s00405-010-1348-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000401648
354 https://doi.org/10.1007/s00405-010-1348-2
355 rdf:type schema:CreativeWork
356 sg:pub.10.1007/s11307-011-0484-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046913665
357 https://doi.org/10.1007/s11307-011-0484-4
358 rdf:type schema:CreativeWork
359 sg:pub.10.1007/s12149-012-0604-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011120417
360 https://doi.org/10.1007/s12149-012-0604-5
361 rdf:type schema:CreativeWork
362 sg:pub.10.1007/s12149-013-0686-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023625651
363 https://doi.org/10.1007/s12149-013-0686-8
364 rdf:type schema:CreativeWork
365 grid-institutes:grid.1374.1 schema:alternateName Department of Nuclear Medicine, Turku University Hospital and University of Turku, Turku, Finland
366 Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland
367 Department of Otorhinolaryngology, Head and Neck Surgery, Turku University Hospital and University of Turku, Turku, Finland
368 schema:name Department of Nuclear Medicine, Turku University Hospital and University of Turku, Turku, Finland
369 Department of Oncology and Radiotherapy, Turku University Hospital and University of Turku, Turku, Finland
370 Department of Otorhinolaryngology, Head and Neck Surgery, Turku University Hospital and University of Turku, Turku, Finland
371 Turku PET Centre, Kiinamyllynkatu 4-8, 20521, Turku, Finland
372 rdf:type schema:Organization
373 grid-institutes:grid.470895.7 schema:alternateName Turku PET Centre, Kiinamyllynkatu 4-8, 20521, Turku, Finland
374 schema:name Turku PET Centre, Kiinamyllynkatu 4-8, 20521, Turku, Finland
375 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...